| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,022 |
944 |
$58K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
99 |
95 |
$14K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
259 |
195 |
$8K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
498 |
497 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
149 |
144 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
327 |
327 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28 |
27 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
115 |
115 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
13 |
13 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$1K |
| 96127 |
|
97 |
97 |
$996.19 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
19 |
18 |
$975.08 |
| 0071A |
|
13 |
13 |
$596.44 |
| 0072A |
|
12 |
12 |
$550.56 |
| 99177 |
|
41 |
41 |
$538.36 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
43 |
41 |
$507.83 |